Cargando…
Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance
The principles of comparability assessments have been accepted globally as offering sensitive and reliable tools with which to evaluate potential changes to biologics that may arise either through processing changes or through the creation of a copy (biosimilar) by a different sponsor. The comparabi...
Autores principales: | Webster, Christopher J., George, Kelly L., Woollett, Gillian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295099/ https://www.ncbi.nlm.nih.gov/pubmed/34143406 http://dx.doi.org/10.1007/s40259-021-00488-5 |
Ejemplares similares
-
A ‘Global Reference’ Comparator for Biosimilar Development
por: Webster, Christopher J., et al.
Publicado: (2017) -
Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
por: George, Kelly, et al.
Publicado: (2019) -
An Efficient Development Paradigm for Biosimilars
por: Webster, Christopher J., et al.
Publicado: (2019) -
Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022) -
Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective
por: Cohen, Hillel P., et al.
Publicado: (2023)